NOPAIN for Veterans Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
Requires the Department of Veterans Affairs to add qualifying non-opioid pain management drugs and biologics to the VA national formulary within set deadlines.
Who Benefits and How
Veterans with acute or postsurgical pain could get faster access to non-opioid pain treatments through the VA system.
Who Bears the Burden and How
VA would have to add eligible products to its formulary on schedule, and formulary spending could rise as additional products are covered.
Key Provisions
- Defines a non-opioid pain management drug or biological product for VA formulary purposes.
- Requires VA to include eligible products in the national formulary within one year of certain payment eligibility or 18 months after FDA approval.
- Bars use of the Cost of War Toxic Exposures Fund to implement the change and requires implementation within 90 days.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Requires the Department of Veterans Affairs to add qualifying non-opioid pain management drugs and biologics to the VA national formulary within set deadlines.
Key Policy Areas
Healthcare, Veterans, Government Operations
Primary Purpose
Requires the Department of Veterans Affairs to add qualifying non-opioid pain management drugs and biologics to the VA national formulary within set deadlines.
Policy Domains
Main Provisions
Identified Gains
Contextual inference, no direct clause citation- Veterans seeking non-opioid pain treatment options
- Manufacturers of qualifying non-opioid pain products
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- Department of Veterans Affairs formulary administrators
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
In CommitteeMrs. Capito (for herself, Mrs. Shaheen, Mr. Cramer, Mr. King, …
Read twice and referred to the Committee on Veterans' Affairs.
Introduced in Senate
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Veterans seeking non-opioid pain treatment options through the VA
Manufacturers of qualifying non-opioid pain drugs and biologics
Department of Veterans Affairs formulary administrators
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology